Glycosidase

Mudanpioside E is a paeoniflorin-type monoterpene glycoside that acts as an antiallergic agent by inhibiting IgE-mediated β-hexosaminidase release with an IC50 of 40.34 μM. It effectively reverses the inhibitory effect of modified extracts of the Xiaoqinglong Decoction on passive cutaneous anaphylaxis in murine models. While Mudanpioside E does not exhibit direct activity against passive cutaneous anaphylaxis, it serves as a valuable tool for research investigating allergic diseases and potential therapeutic strategies.

α-HNJNAc is a potent, competitive inhibitor of hexosaminidases, selectively targeting these enzymes while demonstrating no interference with other glycosidases. This specificity makes α-HNJNAc an invaluable tool for research applications focused on the modulation of glycan metabolism and the study of lysosomal storage disorders. Its ability to inhibit hexosaminidases can aid in unraveling the biochemical pathways involved in glucosamine metabolism and related enzymatic activities.

CHI3L1 binder 1 is a selective CHI3L1 inhibitor with a dissociation constant (Kd) of 182 µM. This compound is valuable for studying various biological processes, including immune response, tissue remodeling, and cancer progression. Its specificity for CHI3L1 makes it a useful tool for researchers investigating the role of this protein in disease mechanisms and therapeutic interventions.